From Liver to Kidney: The Overlooked Burden of Nonalcoholic Fatty Liver Disease in Chronic Kidney Disease
Journal of Clinical Medicine · 05.04.2025 · 14 (7) · 2486
DOI: 10.3390/jcm14072486 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 05.04.2025. Verfasst von Razvan George Bogdan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Plastic Surgery Department, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victor Babeș University of Medicine and Pharmacy Timișoara, VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY TIMIȘOARA.
Abstract (Originalsprache)
Nonalcoholic fatty liver disease (NAFLD) is increasingly recognized as a contributor to chronic kidney disease (CKD), yet its impact remains underappreciated in clinical practice. Recent studies reveal a strong association between NAFLD and CKD progression, with evidence linking hepatic dysfunction to renal impairment through metabolic and inflammatory pathways. NAFLD not only increases the risk of CKD but also accelerates its progression, leading to worse cardiovascular outcomes and higher mortality, particularly in patients with advanced fibrosis. Despite this growing evidence, NAFLD often goes undiagnosed in CKD patients and routine hepatic evaluation is rarely integrated into nephrology care. Emerging diagnostic tools, including noninvasive biomarkers and imaging techniques, offer potential for earlier detection, yet their clinical implementation remains inconsistent. Although lifestyle modifications remain the foundation of treatment, pharmacotherapeutic strategies, including SGLT2 inhibitors and GLP-1 receptor agonists, have demonstrated potential in mitigating both hepatic and renal impairment. Recognizing the interplay between NAFLD and CKD is essential for improving patient outcomes. A multidisciplinary approach, integrating hepatology and nephrology expertise, is crucial to refining screening strategies, optimizing treatment, and reducing the long-term burden of these coexisting conditions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Plastic Surgery Department, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
- Faculty of Medicine, "Lucian Blaga" University of Sibiu, 550024 Sibiu, Romania.
ORCID-Profile: Razvan George Bogdan, Adrian Boicean, Cristian Ichim, Zorin Petrisor Crainiceanu
Förderung
- Victor Babeș University of Medicine and Pharmacy Timișoara
- VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY TIMIȘOARA
Zitieren
APA
Bogdan, R. G., Boicean, A., Anderco, P., Ichim, C., Iliescu-Glaja, M., Todor, S. B., Leonte, E., Bloanca, V. A., Crainiceanu, Z. P., & Popa, M. L. (2025). From Liver to Kidney: The Overlooked Burden of Nonalcoholic Fatty Liver Disease in Chronic Kidney Disease. Journal of Clinical Medicine, 14(7), 2486. https://doi.org/10.3390/jcm14072486
Vancouver
Bogdan RG, Boicean A, Anderco P, Ichim C, Iliescu-Glaja M, Todor SB, et al. From Liver to Kidney: The Overlooked Burden of Nonalcoholic Fatty Liver Disease in Chronic Kidney Disease. Journal of Clinical Medicine. 2025;14(7):2486. doi:10.3390/jcm14072486
BibTeX
@article{Bogdan2025,
author = {Bogdan, Razvan George and Boicean, Adrian and Anderco, Paula and Ichim, Cristian and Iliescu-Glaja, Mihai and Todor, Samuel Bogdan and Leonte, Elisa and Bloanca, Vlad Adam and Crainiceanu, Zorin Petrisor and Popa, Mirela Livia},
title = {From Liver to Kidney: The Overlooked Burden of Nonalcoholic Fatty Liver Disease in Chronic Kidney Disease},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {7},
pages = {2486},
doi = {10.3390/jcm14072486}
}
EUVIMED